|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 430 studies with search of: | leukemia AND new jersey |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Donor Stem Cell Transplant After Total-Body Irradiation in Treating Patients With Relapsed or Refractory Hematologic Cancer or Acute Myeloid Leukemia or Acute Lymphocytic Leukemia in Complete Remission
|
||||
| 2 | Withdrawn |
Collecting and Storing Blood Samples From Patients With Cancer
|
||||
| 3 | Terminated |
Controlling Blood Sugar Levels in Preventing Infection in Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
|
||||
| 4 | Terminated |
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
|
||||
| 5 | Completed |
Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate
|
||||
| 6 | Suspended |
Tetradecanoylphorbol Acetate, Dexamethasone, and Choline Magnesium Trisalicylate in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
|
||||
| 7 | Terminated |
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
|
||||
| 8 | Recruiting |
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
|
||||
| 9 | Terminated |
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
|
||||
| 10 | Terminated |
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
|
||||
| 11 | Unknown † |
Aminopterin in Treating Patients With Refractory Leukemia
|
||||
| 12 | Terminated |
Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia
|
||||
| 13 | Recruiting |
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
|
||||
| 14 | Recruiting |
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
|
||||
| 15 | Recruiting |
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
||||
| 16 | Recruiting |
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
|
||||
| 17 | Recruiting |
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
|
||||
| 18 | Recruiting |
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
|
||||
| 19 | Recruiting |
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
|
||||
| 20 | Recruiting |
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|